

Exchange Rate USD: Thu, 29 May.


- XCEL BRANDS, INC. Receives NASDAQ notice regarding delinquent Form 10-K and Form 10-Q filing
- Pool Corporation Announces Upcoming Investor Conference Participation
- ORIC ® Pharmaceuticals Announces Potentially Best-In-Class Preliminary Efficacy and Safety Data from Ongoing Phase 1b Trial of ORIC-944 in Combination with AR Inhibitors for the Treatment of Patients




